Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae

Clinical trial NCT02116998 · COMPLETED

Trial details

NCT number: NCT02116998
Sponsor: Genocea Biosciences, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pneumococcal Infections Pneumonia, Pneumococcal

Start date: 2014-09-01
Primary completion: 2016-04-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.